Elsevier

Cellular Signalling

Volume 25, Issue 3, March 2013, Pages 707-716
Cellular Signalling

Review
Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling

https://doi.org/10.1016/j.cellsig.2012.11.024Get rights and content

Abstract

G protein-coupled receptors (GPCRs) belong to one of the largest family of signaling receptors in the mammalian genome [1]. GPCRs elicit cellular responses to multiple diverse stimuli and play essential roles in human health and disease. GPCRs have important clinical implications in various diseases and are the targets of approximately 25–50% of all marketed drugs [2], [3]. Understanding how GPCRs are regulated is essential to delineating their role in normal physiology and in the pathophysiology of several diseases. Given the vast number and diversity of GPCRs, it is likely that multiple mechanisms exist to regulate GPCR function. While GPCR signaling is typically regulated by desensitization and endocytosis mediated by phosphorylation and β-arrestins, it can also be modulated by ubiquitination. Ubiquitination is emerging an important regulatory process that may have unique roles in governing GPCR trafficking and signaling. Recent studies have revealed a mechanistic link between GPCR phosphorylation, β-arrestins and ubiquitination that may be applicable to some GPCRs but not others. While the function of ubiquitination is generally thought to promote receptor endocytosis and endosomal sorting, recent studies have revealed that ubiquitination also plays an important role in positive regulation of GPCR signaling. Here, we will review recent developments in our understanding of how ubiquitin regulates GPCR endocytic trafficking and how it contributes to signal transduction induced by GPCR activation.

Highlights

► Ubiquitination regulates GPCR trafficking and signaling. ► Ubiquitination regulates GPCR internalization and endosomal sorting. ► β-arrestin ubiquitination regulates GPCR endocytosis and MAPK signaling. ► β-arrestin regulates GPCR ubiquitination and endosomal sorting. ► GPCR ubiquitination and MAPK signaling may occur independent of β-arrestin.

Introduction

G protein-coupled receptors (GPCRs) belong to the largest family of signaling receptors [1]. GPCRs elicit cellular responses to multiple diverse stimuli and play essential roles in human health and have important clinical implications in various diseases [2], [3]. Upon binding to their cognate ligand, GPCRs typically signal via heterotrimeric GTP-binding proteins (G proteins) [1], [4], [5]. Heterotrimeric G proteins are comprised of an α-subunit (Gα) and a tightly associated β and γ-subunits (Gβγ). In the inactive state Gα is bound to GDP and once the GPCR is activated by its cognate ligand, conformational changes in the receptor induce the exchange of GDP for GTP on Gα leading to its activation and dissociation from the βγ subunits. The activated Gα (Gα-GTP) and dissociated βγ subunits activate downstream effector molecules contributing to GPCR signaling. One common effector molecule is adenylyl cyclase that catalyzes formation cyclic AMP (cAMP), which in turn activates the protein kinase A (PKA), a serine/threonine kinase that phosphorylates numerous substrates. Another effector molecule that is activated by predominantly Gαq is phospholipase C, which mediates the hydrolysis of phosphatidyl 4,5 bisphosphate to produce inositol 1,4,5-trisphosphate and diacyclglycerol, which in turn leads to calcium mobilization from intracellular stores and activation of protein kinase C (PKC), respectively. GPCRs may also signal independent of heterotrimeric G proteins, and this typically involves signaling by β-arrestins [6], [7]. β-Arrestins are best known to negatively regulate GPCR signaling via desensitization and endocytosis; however, β-arrestins also function as scaffolds that initiate new modes of GPCR signaling [8], [9], [10]. These properties of β-arrestins will be discussed below.

To ensure that signals are of the appropriate magnitude and duration, GPCR signaling is tightly regulated. Regulation of GPCR signaling involves multiple distinct temporal events that occur at the level of the receptor, G protein and downstream effector molecules [11], [12]. The latter steps include inactivation of the G protein and degradation of second messengers [13], [14]. Regulation at the level of the receptor involves a series of events, including receptor interactions with various cytosolic proteins and regulation by post-translational modifications such as phosphorylation and ubiquitination [11], [12]. Phosphorylation may occur by second-messenger-dependent protein kinases PKA and PKC, which promote GPCR signaling by phosphorylating effector molecules, but also function in a negative feedback loop by phosphorylating and desensitizing the GPCR to attenuate further signaling in a homologous or heterologous manner. Phosphorylation may also occur by another family of serine/threonine kinases known as G protein-coupled receptor kinases (GRKs). These kinases preferentially phosphorylate the activated or ligand bound form of the GPCR leading to homologous desensitization [11].

Phosphorylation by GRKs enhances GPCR binding to arrestins. Mammalian arrestins comprise a family of four proteins that can be sub-divided into two groups: visual (arrestin-1 and arrestin-4) and non-visual arrestins (β-arrestin-1 and β-arrestin-2, also known as arrestin-2 and arrestin-3, respectively) [15]. Expression of arrestin-1 and -4 is restricted to the visual system. Arrestin-1 is found in high abundance in rod cells whereas arrestin-4 is found in cone cells. In contrast, non-visual arrestins are ubiquitously expressed and regulate the signaling of most GPCRs. The classical function of arrestins is to mediate GPCR desensitization. Arrestins are typically recruited to the plasma membrane by activated GPCRs that are phosphorylated by GRKs [11]. Arrestin binding uncouples the receptor from G proteins via steric hindrance culminating in attenuated signaling [16]. Non-visual or β-arrestins promote GPCR internalization through clathrin-coated pits by binding directly to clathrin and β2-adaptin, two important components of the internalization machinery [17], [18]. Arrestins may also contribute to signal termination by promoting degradation of certain second messengers [13], [14].

In addition to established roles of phosphorylation and arrestin binding, recent studies have shown a critical function for ubiquitination of GPCRs in signal regulation. Over the past 10 years, numerous studies have documented that GPCRs and associated proteins are post-translationally modified by ubiquitination and shown an important role for ubiquitination in regulation of various aspects of receptor signaling and trafficking. Here, we will discuss how certain GPCRs are modified by ubiquitination, the function of GPCR ubiquitination and recent developments of the role for ubiquitin and other ubiquitin-like post-translational modifications on GPCR trafficking and signaling.

Section snippets

The ubiquitination machinery

Ubiquitin is an evolutionary conserved 76 amino acid polypeptide that is typically attached to proteins through the formation of an isopeptide bond between the carboxyl terminus of ubiquitin and the ε-amino group of lysine side chains on target proteins [19], [20]. This ATP-dependent linkage is catalyzed by the sequential activity of three enzymes: ubiquitin-activating enzyme (E1), ubiquitin-conjugating (UBC) enzyme (E2), and ubiquitin ligase (E3). First, ATP is linked to the C-terminal glycine

The ESCRT machinery

Ubiquitinated membrane proteins are sorted to intraluminal vesicles (ILVs) of multivesicular bodies (MVBs) via the ESCRT machinery [54], [55], [56]. This machinery is comprised of 4 distinct protein complexes (ESCRT-0, -I, -II and -III) that act in a sequential and coordinated manner with accessory factors to sort ubiquitinated cargo into ILVs of MVBs. ESCRT-0 is comprised of two subunits HRS and STAM [57], [58]. Each of these subunits can bind to ubiquitin through multiple UBDs in vitro and

A role for ubiquitin in GPCR trafficking

The first studies that lead to the discovery of ubiquitin function in GPCR trafficking came from examining internalization of the yeast α-mating factor GPCR sterol 2 (Ste2p). Truncation mutagenesis studies aimed at identifying determinants within the carboxy-terminal tail (C-tail) responsible for receptor internalization revealed a 9-amino acid motif sequence (S331INNDAKSS339) that was necessary and sufficient for promoting receptor internalization [71]. Mutation of the lysine (K337) residue to

β-Arrestins and ubiquitin-dependent signaling

Although ubiquitin functions to negatively regulate GPCR signaling by facilitating downregulation, it can also positively regulate GPCR signaling [9]. This is especially relevant to GPCR activation of the MAPK (mitogen-activated protein kinase) signaling cascades, including activation of extracellular signal-regulated kinases-1/2 (ERK-1/2) [7]. GPCR-induced activation of ERK-1/2 occurs through both G protein-dependent and -independent mechanisms [126], [127]. G protein-dependent activation of

Role of ubiquitin-like molecules in GPCR regulation

Ubiquitin belongs to a family of proteins known as ubiquitin-like molecules [134]. SUMO (small ubiquitin-like modifier) is a member of the ubiquitin-like molecules and is structurally related to ubiquitin but they share little amino acid identity. SUMO modification of proteins has been linked to several processes such as DNA repair, chromatin remodeling and signal transduction [135], [136], [137]. Unlike ubiquitination, proteins that are modified by SUMO typically have a SUMO consensus motif,

Conclusion

Ubiquitin has emerged as an important post-translational modification in the regulation of GPCR signaling. Recent developments have led to a greater understanding of the role ubiquitin plays in GPCR endocytosis and endosomal sorting and it is emerging that ubiquitin also has diverse roles in positive regulation of GPCR signaling. Although several GPCRs are modified by ubiquitin and are regulated by similar modifying enzymes, it appears that GPCRs are differentially regulated by ubiquitination,

References (142)

  • J.J. Kovacs et al.

    Developmental Cell

    (2009)
  • J.J. Kovacs et al.

    Developmental Cell

    (2009)
  • S.K. Shenoy et al.

    Trends in Pharmacological Sciences

    (2011)
  • C.M. Pickart et al.

    Biochimica et Biophysica Acta

    (2004)
  • S.M. Nijman et al.

    Cell

    (2005)
  • A.Y. Amerik et al.

    Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

    (2004)
  • C. Jacob et al.

    The Journal of Biological Chemistry

    (2005)
  • R. Dunn et al.

    The Journal of Biological Chemistry

    (2001)
  • M.J. Macias et al.

    FEBS Letters

    (2002)
  • A. Marchese et al.

    Developmental Cell

    (2003)
  • S.K. Shenoy et al.

    The Journal of Biological Chemistry

    (2008)
  • A.G. Henry et al.

    Developmental Cell

    (2012)
  • V. Kirkin et al.

    Current Opinion in Cell Biology

    (2007)
  • S. Rahighi et al.

    Cell

    (2009)
  • W.M. Henne et al.

    Developmental Cell

    (2011)
  • X. Ren et al.

    Structure

    (2009)
  • J.H. Hurley

    Current Opinion in Cell Biology

    (2008)
  • J.H. Hurley et al.

    Cell

    (2010)
  • J.E. Garrus et al.

    Cell

    (2001)
  • L. Hicke et al.

    Cell

    (1996)
  • D.J. Katzmann et al.

    Cell

    (2001)
  • M. Babst et al.

    Developmental Cell

    (2002)
  • M. Babst et al.

    Developmental Cell

    (2002)
  • A. Marchese et al.

    The Journal of Biological Chemistry

    (2001)
  • P.J. Baugher et al.

    The Journal of Biological Chemistry

    (2008)
  • D. Bhandari et al.

    The Journal of Biological Chemistry

    (2007)
  • Y.M. Li et al.

    Cancer Cell

    (2004)
  • K. Xiao et al.

    The Journal of Biological Chemistry

    (2011)
  • C.H. Lin et al.

    Cell

    (2008)
  • C.E. Groer et al.

    The Journal of Biological Chemistry

    (2011)
  • J.N. Hislop et al.

    The Journal of Biological Chemistry

    (2011)
  • S.M. Foord et al.

    Pharmacological Reviews

    (2005)
  • J. Drews

    Science

    (2000)
  • A.L. Hopkins et al.

    Nature Reviews. Drug Discovery

    (2002)
  • R.J. Lefkowitz

    Acta Physiologica

    (2007)
  • W.M. Oldham et al.

    Nature Reviews. Molecular Cell Biology

    (2008)
  • S.M. DeWire et al.

    Annual Review of Physiology

    (2007)
  • E. Reiter et al.

    Annual Review of Pharmacology and Toxicology

    (2012)
  • J.G. Krupnick et al.

    Annual Review of Pharmacology and Toxicology

    (1998)
  • C.A. Moore et al.

    Annual Review of Physiology

    (2007)
  • S.J. Perry et al.

    Science

    (2002)
  • C.D. Nelson et al.

    Science

    (2007)
  • E.V. Gurevich et al.

    Genome Biology

    (2006)
  • M.J. Lohse et al.

    Science

    (1990)
  • O.B. Goodman et al.

    Nature

    (1996)
  • S.A. Laporte et al.

    Proceedings of the National Academy of Sciences of the United States of America

    (1999)
  • A. Hershko et al.

    Annual Review of Biochemistry

    (1998)
  • M.B. Metzger et al.

    Journal of Cell Science

    (2012)
  • T.T. Huang et al.

    Nature Cell Biology

    (2006)
  • C.B. Thien et al.

    Nature Reviews. Molecular Cell Biology

    (2001)
  • Cited by (70)

    • Endocytic sorting and downregulation of the M2 acetylcholine receptor is regulated by ubiquitin and the ESCRT complex

      2020, Neuropharmacology
      Citation Excerpt :

      Lysosomal trafficking for a large number of membrane proteins requires ubiquitination of lysine residues within the intracellular domain (Raiborg and Stenmark, 2009). Protein ubiquitination promotes interaction with a number of ubiquitin-interacting proteins, including those that comprise the ESCRT complex, that target the protein to the lysosome (Katzmann et al., 2002; Raiborg et al., 2003), however, the role of ubiquitination and the ESCRT has remained less clear for GPCRs (Hislop et al., 2009; Marchese and Trejo, 2013). To determine if ubiquitination and the ESCRT are responsible for regulating the lysosomal sorting of M2R, we initially investigated whether M2R colocalized with the core component of ESCRT 0, HRS (Bache et al., 2003).

    View all citing articles on Scopus
    1

    Tel.: +1 858 246 0150.

    View full text